StratifiCare Company
%20.jpg)
StratifiCare is a medical company that focuses on the development and manufacturing of in vitro diagnostic medical devices it provides solutions for personalized medicine. StratifiCare features a panel of biomarkers which are able to determine the progress of dengue fever. The company was founded on July 13, 2015, and headquartered in Singapore.
Technology:
Biomarkers
Headquarters:
Singapore
Funding Status:
Seed
Founded Date:
7-13
Last Funding Type:
Seed
Last Funding Date:
43708
Estimated Revenue:
$1M to $10M
Employee Number:
43840
Total Funding:
1-2
Industry:
Biotechnology, Health Care, Hospital, Information Technology, Manufacturing
Investor Type:
For Profit